Indeed, compared to normal CD4+ T cells, gained CTCF sites in T-ALL interact more frequently with “dynamic” NOTCH1 binding sites, previously defined as those sensitive to gamma-secretase inhibitor (γSI) treatment followed by inhibitor washout [13] (Additional file 1: Fig. S14d). Here, CTCF is linked to acute lymphoblastic leukemia.